Alaunos Therapeutics (TCRT) EV/EBIT: History & Chart

Alaunos Therapeutics, Inc.(TCRT)

Biotechnology · Fort Lauderdale, FL

$0.76-0.03 (-4.29%)

Delayed quote: Oct 6, 2026, 2:12 PM EDT

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., a research and development partnership with The University of Texas MD Anderson Cancer Center, and both a patent licensing and R&D agreement with the National Cancer Institute. Previously known as ZIOPHARM Oncology, Inc., the company adopted its current name, Alaunos Therapeutics, Inc., in January 2022. Its headquarters are located in Houston, Texas.

Fort Lauderdale, FL

1 employees

www.alaunos.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Holger Weis

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Alaunos Therapeutics, Inc. (TCRT)	$1.86M	N/A	N/A	N/A	N/A
TransCode Therapeutics, Inc. (RNAZ)vs ›	$1.84M	N/A	N/A	N/A	N/A
Tenon Medical, Inc. (TNON)vs ›	$1.85M	N/A	N/A	N/A	N/A
Profusa, Inc. Common Stock (PFSA)vs ›	$1.88M	N/A	N/A	N/A	N/A
Beyond Air, Inc. (XAIR)vs ›	$1.89M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.93M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.64M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.48M	N/A	N/A	N/A	N/A
PMGC Holdings Inc. (ELAB)vs ›	$1.47M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.46M	N/A	439.92x	439.92x	439.92x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Alaunos Therapeutics, Inc. (TCRT)

$1.86M

N/A

TransCode Therapeutics, Inc. (RNAZ)vs ›

$1.84M

N/A

Tenon Medical, Inc. (TNON)vs ›

$1.85M